
- 1,078 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
eBook - ePub
About this book
Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside, Third Edition comprehensively investigates key discoveries in the field of bone biology. New aspects of bone cancer biology are treated in new chapters covering exosomes, autophagy, and metabolism. These have led to the development of entirely new areas for investigation, such as therapies which combine surgery and biological approaches.
The Third Edition expands on the original overview of bone cancer development (physiology and pathophysiology), with 40% new material. Each chapter has been written by internationally recognized specialists on the bone cancer microenvironment, bone metastases, osteoclast biology in bone cancer, proteomics, bone niche, circulating tumor cells, and clinical trials.
Given the global prevalence of breast and prostate cancers, knowledge of bone biology has become essential for everyone within the medical and cancer research communities. Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside continues to offer the only translational reference to cover all aspects of primary bone cancer and bone metastases. This revision opens the door to myeloma with two short chapters dedicated to this bone-associated disease.
- Covers the broad field of bone sarcomas and bone metastases from basic research to clinical approaches
- Presents comprehensive and translational overview of biological and clinical aspects of bone cancers, discussing pathophysiology from genetic and molecular levels using the most recent evidence
- Provides a common language for cancer researchers, bone biologists, oncologists, and radiologists to discuss bone tumors and how bone cancer metastases affects each major organ system
- Offers insights to research clinicians (oncologists and radiologists) into understanding the molecular basis of bone cancer, leading to more well-informed diagnoses and treatment of tumors and metastases
- Offers insights to bone biologists into how clinical observations and practices can feed back into the research cycle and, therefore, can contribute to the development of more targeted genomic and proteomic assays
Frequently asked questions
Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Bone Cancer by Dominique Heymann in PDF and/or ePUB format, as well as other popular books in Biological Sciences & Endocrinology & Metabolism. We have over one million books available in our catalogue for you to explore.
Information
Table of contents
- Bone Cancer
- Chapter 1 Cancer
- Chapter 2 Epidemiology of primary bone tumors and economical aspects of bone metastases
- Chapter 3 Mammalian models of bone sarcomas
- Chapter 4 In vivo models used in studies of bone metastases
- Chapter 5 Zebrafish models for studying bone tumors
- Chapter 6 Use of machine learning in bone cancers
- Chapter 7 Artificial intelligence for bone cancer imaging
- Chapter 8 Technical aspects
- Chapter 9 Bone niche and bone metastases
- Chapter 10 Bone, a fertile soil for tumor development
- Chapter 11 Osteomimicry
- Chapter 12 The role of mesenchymal stem cells in bone cancer
- Chapter 13 Technical approaches for studying the communications between osteocytes and cancer cells
- Chapter 14 Osteocytes and bone tumor niche
- Chapter 15 Immune functions of osteoclasts
- Chapter 16 The immune environment of bone sarcomas
- Chapter 17 Macrophages and pathophysiology of bone cancers
- Chapter 18 Growth factors, cytokines, and pediatric malignant primary bones tumors
- Chapter 19 Effects of NF-κB manipulation on cancer-associated bone disease
- Chapter 20 Transforming growth factor-β and its signaling pathway in skeletal complications of malignancy
- Chapter 21 Extracellular vesicles, tumor growth, and the metastatic process
- Chapter 22 Connexin43 and development of primary bone tumors
- Chapter 23 Role of classical cannabinoid receptors in cancer-associated bone disease
- Chapter 24 Impact of the acid microenvironment on bone cancers
- Chapter 25 Hypoxia-inducible factor (HIF)–mediated effects of the hypoxic niche in bone cancer
- Chapter 26 Energy metabolism in bone tumors
- Chapter 27 EMT process in bone metastasis
- Chapter 28 Cancer stem cells and clonal evolution in bone sarcomas
- Chapter 29 Dormancy in cancer bone metastasis
- Chapter 30 Bone remodeling markers and bone cancer
- Chapter 31 Epigenetic heterogeneity in primary bone cancers
- Chapter 32 MicroRNA implication in therapeutic resistance and metastatic dissemination of bone-associated tumors
- Chapter 33 MicroRNAs and bone metastasis
- Chapter 34 Long noncoding RNA and bone sarcoma
- Chapter 35 Liquid biopsy in bone sarcomas and identification of new biomarkers
- Chapter 36 Disseminated tumor cells in bone marrow of cancer patients
- Chapter 37 Cytogenetics of bone tumors
- Chapter 38 Genetic aspects of primary bone tumors
- Chapter 39 Markers for bone sarcomas
- Chapter 40 Molecular pathology of osteosarcoma
- Chapter 41 Genomic and proteomic profiling of osteosarcoma
- Chapter 42 Ewing's sarcoma family of tumors
- Chapter 43 Molecular aspects of Ewing's sarcomas
- Chapter 44 Osteoclast-rich lesions of bone
- Chapter 45 Biology of cartilage tumor family
- Chapter 46 Imaging of bone sarcomas
- Chapter 47 Current therapeutic approaches of bone sarcomas
- Chapter 48 What is an adequate margin after bone tumor resection?
- Chapter 49 Regulated cell death and drug resistance in malignant bone tumors
- Chapter 50 Chondrosarcoma of bone
- Chapter 51 Radiation therapy for primary bone tumors
- Chapter 52 New therapeutic advances of bone sarcomas
- Chapter 53 The histopathology of skeletal metastases
- Chapter 54 Identification of new therapeutic targets of bone cancers by proteomic strategies
- Chapter 55 Interventional radiologic techniques in the management of bone tumors
- Chapter 56 Diagnosis of bone metastases in urological malignancies—an update
- Chapter 57 Mechanisms and management of bone cancer pain
- Chapter 58 Involvement of sympathetic nerves in bone metastasis
- Chapter 59 Pain control with palliative radiotherapy in patients with bone metastases
- Chapter 60 Palliative care for patients with bone metastases
- Chapter 61 Role of radiation therapy in patients with bone metastasis
- Chapter 62 Cellular and molecular actions of bisphosphonates
- Chapter 63 Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases
- Chapter 64 Bone metastases—current status of bone-targeted treatments
- Chapter 65 Therapies of bone metastases in castration-resistant prostate cancer
- Chapter 66 Targeted radionuclide therapy in bone cancer
- Chapter 67 The effects of anticancer therapies on bone metastases in breast cancer
- Chapter 68 Biological relationship between bone and myeloma cells
- Chapter 69 Recent therapeutic approaches in myeloma
- Index